BLNK vs DMAAR · rev $42.5M vs $1.8M cap
Blink Charging Co (BLNK) versus Drugs Made In America Acquisition Corp. Rights (DMAAR) — a side-by-side from cached financials, not a winner call.
Blink Charging Co (BLNK) is a engineering & construction company listed on NASDAQ.
Drugs Made In America Acquisition Corp. Rights (DMAAR) common stock listed on US.
Latest reported BLNK revenue for 2026-06-30 was $42.5M. Net income was -$17.6M. BLNK currently screens at market cap $94.0M.
DMAAR does not have a complete income-statement cache yet.
BLNK currently screens at market cap $94.0M. DMAAR currently screens at market cap $1.8M.
Not investment advice. Open the BLNK and DMAAR stock pages for the full models.
Not investment advice.